Literature DB >> 28892041

Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme.

Gavin J Knott1, Alexandra East-Seletsky1, Joshua C Cofsky1, James M Holton2,3,4, Emeric Charles1, Mitchell R O'Connell1, Jennifer A Doudna1,2,5,6,7.   

Abstract

CRISPR adaptive immune systems protect bacteria from infections by deploying CRISPR RNA (crRNA)-guided enzymes to recognize and cut foreign nucleic acids. Type VI-A CRISPR-Cas systems include the Cas13a enzyme, an RNA-activated RNase capable of crRNA processing and single-stranded RNA degradation upon target-transcript binding. Here we present the 2.0-Å resolution crystal structure of a crRNA-bound Lachnospiraceae bacterium Cas13a (LbaCas13a), representing a recently discovered Cas13a enzyme subtype. This structure and accompanying biochemical experiments define the Cas13a catalytic residues that are directly responsible for crRNA maturation. In addition, the orientation of the foreign-derived target-RNA-specifying sequence in the protein interior explains the conformational gating of Cas13a nuclease activation. These results describe how Cas13a enzymes generate functional crRNAs and how catalytic activity is blocked before target-RNA recognition, with implications for both bacterial immunity and diagnostic applications.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28892041      PMCID: PMC5961731          DOI: 10.1038/nsmb.3466

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  40 in total

1.  XDS.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

2.  Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.

Authors:  Aaron A Smargon; David B T Cox; Neena K Pyzocha; Kaijie Zheng; Ian M Slaymaker; Jonathan S Gootenberg; Omar A Abudayyeh; Patrick Essletzbichler; Sergey Shmakov; Kira S Makarova; Eugene V Koonin; Feng Zhang
Journal:  Mol Cell       Date:  2017-01-05       Impact factor: 17.970

3.  Structural basis for microRNA targeting.

Authors:  Nicole T Schirle; Jessica Sheu-Gruttadauria; Ian J MacRae
Journal:  Science       Date:  2014-10-31       Impact factor: 47.728

4.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

5.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

6.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Silvana Konermann; Julia Joung; Ian M Slaymaker; David B T Cox; Sergey Shmakov; Kira S Makarova; Ekaterina Semenova; Leonid Minakhin; Konstantin Severinov; Aviv Regev; Eric S Lander; Eugene V Koonin; Feng Zhang
Journal:  Science       Date:  2016-06-02       Impact factor: 47.728

7.  Sequence- and structure-specific RNA processing by a CRISPR endonuclease.

Authors:  Rachel E Haurwitz; Martin Jinek; Blake Wiedenheft; Kaihong Zhou; Jennifer A Doudna
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

8.  Enhancement of the seed-target recognition step in RNA silencing by a PIWI/MID domain protein.

Authors:  James S Parker; Eneida A Parizotto; Muhan Wang; S Mark Roe; David Barford
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

9.  Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias.

Authors:  Thomas C Terwilliger; Ralf W Grosse-Kunstleve; Pavel V Afonine; Nigel W Moriarty; Paul D Adams; Randy J Read; Peter H Zwart; Li-Wei Hung
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-04-19

Review 10.  Anatomy of RISC: how do small RNAs and chaperones activate Argonaute proteins?

Authors:  Kotaro Nakanishi
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-05-16       Impact factor: 9.957

View more
  37 in total

Review 1.  Programmable RNA manipulation in living cells.

Authors:  Yu Pei; Mingxing Lu
Journal:  Cell Mol Life Sci       Date:  2019-07-31       Impact factor: 9.261

2.  Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.

Authors:  Beibei Wang; Tianlong Zhang; Jun Yin; You Yu; Wenhao Xu; Jianping Ding; Dinshaw J Patel; Hui Yang
Journal:  Mol Cell       Date:  2021-01-19       Impact factor: 17.970

Review 3.  Class 2 CRISPR-Cas RNA-guided endonucleases: Swiss Army knives of genome editing.

Authors:  Stefano Stella; Pablo Alcón; Guillermo Montoya
Journal:  Nat Struct Mol Biol       Date:  2017-10-16       Impact factor: 15.369

4.  RNA-targeting CRISPR comes of age.

Authors:  V Narry Kim
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908

5.  Interfering with retrotransposition by two types of CRISPR effectors: Cas12a and Cas13a.

Authors:  Niubing Zhang; Xinyun Jing; Yuanhua Liu; Minjie Chen; Xianfeng Zhu; Jing Jiang; Hongbing Wang; Xuan Li; Pei Hao
Journal:  Cell Discov       Date:  2020-05-19       Impact factor: 10.849

6.  It takes two (Las1 HEPN endoribonuclease domains) to cut RNA correctly.

Authors:  Monica C Pillon; Kevin H Goslen; Jacob Gordon; Melissa L Wells; Jason G Williams; Robin E Stanley
Journal:  J Biol Chem       Date:  2020-03-27       Impact factor: 5.157

7.  RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a.

Authors:  Akshay Tambe; Alexandra East-Seletsky; Gavin J Knott; Jennifer A Doudna; Mitchell R O'Connell
Journal:  Cell Rep       Date:  2018-07-24       Impact factor: 9.423

8.  Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d.

Authors:  Cheng Zhang; Silvana Konermann; Nicholas J Brideau; Peter Lotfy; Xuebing Wu; Scott J Novick; Timothy Strutzenberg; Patrick R Griffin; Patrick D Hsu; Dmitry Lyumkis
Journal:  Cell       Date:  2018-09-20       Impact factor: 41.582

Review 9.  CRISPR-Based Technologies: Impact of RNA-Targeting Systems.

Authors:  Michael P Terns
Journal:  Mol Cell       Date:  2018-11-01       Impact factor: 17.970

Review 10.  Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection.

Authors:  Chun-Hao Huang; Ko-Chuan Lee; Jennifer A Doudna
Journal:  Trends Cancer       Date:  2018-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.